Capricor Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. ACN
10. USO

Go back to Capricor Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Capricor Therapeutics (CAPR) Reports Q2 Loss of $0.59

August 6, 2019 4:54 PM EDT

Capricor Therapeutics (NASDAQ: CAPR) reported Q2 EPS of ($0.59), versus ($1.42) reported last year. Revenue for the quarter came in at $410.35 thousand versus the consensus estimate of $231 thousand.

"This has been a very exciting quarter as we previously reported the outcome of our pre-specified... More